Cargando…

Molecular Classification in Patients With Endometrial Cancer After Fertility-Preserving Treatment: Application of ProMisE Classifier and Combination of Prognostic Evidence

The Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) is a molecular classification system that identifies endometrial cancer (EC) into four prognostically distinct subtypes: POLE-mutated, mismatch repair deficiency (MMR-D), p53 wild-type (p53wt), and p53 abnormal (p53abn). Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ran, Xuting, Hu, Tingwenyi, Li, Zhengyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160735/ https://www.ncbi.nlm.nih.gov/pubmed/35664732 http://dx.doi.org/10.3389/fonc.2022.810631

Ejemplares similares

Combination of Proactive Molecular Risk Classifier for Endometrial cancer (ProMisE) with sonographic and demographic characteristics in preoperative prediction of recurrence or progression of endometrial cancer
por: Eriksson, L. S. E., et al.
Publicado: (2021)

Outcomes of fertility preservation treatments in patients with endometrial cancer with different molecular classifications based on an NGS panel
por: Xu, Yan, et al.
Publicado: (2023)

Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer
por: Raffone, Antonio, et al.
Publicado: (2021)

The Advance and Correlation of KRAS Mutation With the Fertility-Preservation Treatment of Endometrial Cancer in the Background of Molecular Classification Application
por: Yu, KeXuan, et al.
Publicado: (2021)

Insulin Resistance and Metabolic Syndrome Increase the Risk of Relapse For Fertility Preserving Treatment in Atypical Endometrial Hyperplasia and Early Endometrial Cancer Patients
por: Li, Xingchen, et al.
Publicado: (2021)

Comparison of Laparoscopic and Open Surgery for Women With Early-Stage Epithelial Ovarian Cancer
por: Ran, Xuting, et al.
Publicado: (2022)

Clinical implications of morular metaplasia in fertility-preserving treatment for atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Wu, Pengfei, et al.
Publicado: (2022)

Differential impact of clinicopathological risk factors within the 2 largest ProMisE molecular subgroups of endometrial carcinoma
por: Pasanen, Annukka, et al.
Publicado: (2021)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
por: Chen, Junyu, et al.
Publicado: (2022)

Maintenance Therapy Can Improve the Oncologic Prognosis and Obstetrical Outcome of Patients With Atypical Endometrial Hyperplasia and Endometrial Cancer After Fertility-Preserving Treatment: A Multicenter Retrospective Study
por: He, Yijiao, et al.
Publicado: (2021)

Editorial: Fertility-preserving and fertility-sparing treatment approaches in gynecologic malignancies
por: Raimondo, Diego, et al.
Publicado: (2023)

Fertility preserving management of early endometrial cancer in a patient cohort at the department of women’s health at the university of Tuebingen
por: Andress, Jürgen, et al.
Publicado: (2021)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
por: Chen, Junyu, et al.
Publicado: (2021)

Autophagy Machinery as a Promising Therapeutic Target in Endometrial Cancer
por: Nuñez-Olvera, Stephanie I., et al.
Publicado: (2019)

The Perspectives of Fertility Preservation in Women with Endometrial Cancer
por: Knez, Jure, et al.
Publicado: (2021)

Fertility-preservation in endometrial cancer: is it safe? Review of the literature
por: Carneiro, Márcia Mendonça, et al.
Publicado: (2016)

Fertility preservation in women with cervical, endometrial or ovarian cancers
por: Feichtinger, Michael, et al.
Publicado: (2016)

Fertility Preservation in Endometrial Cancer—Treatment and Molecular Aspects
por: Schubert, Melanie, et al.
Publicado: (2023)

PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
por: Remmerie, Michiel, et al.
Publicado: (2019)

Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer
por: Angarita, Ana Milena, et al.
Publicado: (2016)

Fertility Preservation in Cancer Patients During the Coronavirus (COVID-19) Pandemic
por: Dellino, Miriam, et al.
Publicado: (2020)

Current and Emerging Prognostic Biomarkers in Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2022)

Machine Learning for Endometrial Cancer Prediction and Prognostication
por: Bhardwaj, Vipul, et al.
Publicado: (2022)

Analysis of Factors Associated With Recurrence of Early-Stage Endometrial Carcinoma and Atypical Endometrial Hyperplasia in Infertile Women After In Vitro Fertilization Treatment
por: Guo, Yaxing, et al.
Publicado: (2022)

The role of TCGA molecular classification in clear cell endometrial carcinoma
por: Tang, Xinyue, et al.
Publicado: (2023)

Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer
por: Ronsini, Carlo, et al.
Publicado: (2022)

Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer
por: Parmar, Chintan, et al.
Publicado: (2015)

Cancer, Fertility and Me: Developing and Testing a Novel Fertility Preservation Patient Decision Aid to Support Women at Risk of Losing Their Fertility Because of Cancer Treatment
por: Jones, Georgina L., et al.
Publicado: (2022)

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy
por: Ga, Hiromi, et al.
Publicado: (2023)

Prognostic factors of oncologic outcomes after fertility-preservative management with progestin in early-stage of endometrial cancer
por: Roh, Hyun Jin, et al.
Publicado: (2021)

Perspectives of Young Women With Gynecologic Cancers on Fertility and Fertility Preservation: A Systematic Review
por: Gonçalves, Vânia, et al.
Publicado: (2022)

Fertility Preservation in Female Pediatric Patients With Cancer: A Clinical and Regulatory Issue
por: Brancati, Serena, et al.
Publicado: (2021)

The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer
por: Blondeaux, Eva, et al.
Publicado: (2021)

Preserving fertility in young patients with endometrial cancer: current perspectives
por: Kalogera, Eleftheria, et al.
Publicado: (2014)

Fertility preservation in endometrial cancer patients: options, challenges and perspectives
por: Terzic, Milan, et al.
Publicado: (2020)

Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT
por: von Wolff, Michael, et al.
Publicado: (2011)

Effect and Management of Excess Weight in the Context of Fertility-Sparing Treatments in Patients With Atypical Endometrial Hyperplasia and Endometrial Cancer: Eight-Year Experience of 227 Cases
por: Shan, Ying, et al.
Publicado: (2021)

Prognostication in palliative radiotherapy—ProPaRT: Accuracy of prognostic scores
por: Maltoni, Marco, et al.
Publicado: (2022)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
por: Guan, Jun, et al.
Publicado: (2022)

Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma
por: Yu, Mei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p4ojc80ipd7841qqjmg0t0uvme